英国纽卡斯尔大学功能筛查的有效药物组合成神经管细胞瘤方向博士后
信息来源:未知 | 作者:admin | 时间:2015-09-24 11:46
【简介】博士后招聘网整理分享“英国纽卡斯尔大学功能筛查的有效药物组合成神经管细胞瘤方向博士后”,浏览查询更多博士后招聘计划请访问博士后招聘网。
PhD Studentship - Functional screening for effective drug combinations in medulloblastoma
Newcastle University
Qualification type: | PhD |
Location: | Newcastle Upon Tyne |
Funding for: | UK Students, EU Students |
Funding amount: | £14,196 |
Hours: | Full Time |
Placed on: | 22nd September 2015 |
Closes: | 10th October 2015 |
Reference: | CR071 |
Value, Duration and Start Date of the Award
The award covers University fees at the Home/EU rate and a stipend of £14,196 (2015-16) for the four-year duration of your PhD. International students may apply but must fund the difference between the Home/EU rate and the overseas rate.
Project Start Date: November 2015.
Sponsor
This studentship is funded by Blue Skye Thinking.
Project description
Medulloblastoma accounts for 10% of childhood cancer deaths and there remains an urgent need for innovative therapies which could lead to improved outcomes. Clinical challenges encompass both the need to improve survival rates (currently approximately 70%), and to reduce therapy-related toxicities in surviving patients [1].
Recent advances in our understanding of medulloblastoma biology have identified a number of critical biological pathways in tumour development, and this has led to initiatives to target these pathways therapeutically using novel pathway-specific drugs [2].
This project aims to use contemporary molecular tools and experimental disease models to identify effective drug combinations which could be advanced towards clinical use for medulloblastoma. Gene editing using the CRISPR-CAS9 system provides an exciting new tool, which allows us to systematically assess the functional impact of each gene in the human genome on disease behaviour. We will apply this technology to our novel cell-based models of critical biological changes in medulloblastoma (e.g. MYC), and use these to identify candidate combination therapies and genetic dependencies, which could be exploited to target MYC-dependent medulloblastoma.
Northern Institute for Cancer Research (NICR) is the focus of research excellence in translational cancer research at Newcastle University with over 250 personnel and an annual research income of between £8m and £10m.
References:
1. Pizer BL and Clifford SC. Br J Neurosurg. 2009; 23(4):364-375.
2. Taylor MD, et al Acta Neuropathol. 2012; 123(4):465-472.
请您在邮件申请时在标题注明信息来自:博士后招聘网-boshihoujob.com,电话咨询时说明从博士后招聘网(www.boshihoujob.com)看到的博士后招聘信息。
声明:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜,请与我们联系。邮箱:boshihoujob@163.com。